Pierre Bel-Lassen

8PUBLICATIONS
61CO-AUTHORS
Gene and molecular therapyPainNutrigenomics and personalised nutritionMicrobial geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 06, 2026
Glycemic and Renal Effects of SGLT2 Inhibitors in Monogenic Diabetes: A Real-World National Study.

|Mar 26, 2026
SEMASEARCH Study Design: Real-World Evaluation of Semaglutide 2.4 mg in Adults With Severe Obesity Underrepresented in Clinical Trials.

Pierre Bel Lassen, David Jacobi, Marie-Claude Brindisi

|Dec 18, 2025
Prominent mediatory role of gut microbiome in the effect of lifestyle on host metabolic phenotypes.

Solia Adriouch, Eugeni Belda, Timothy D Swartz

|Apr 18, 2022
The human gut microbiota contributes to type-2 diabetes non-resolution 5-years after Roux-en-Y gastric bypass.

Jean Debédat, Tiphaine Le Roy, Lise Voland

|Feb 09, 2022
Obesity Due to Steroid Receptor Coactivator-1 Deficiency Is Associated With Endocrine and Metabolic Abnormalities.

Tessa M Cacciottolo, Elana Henning, Julia M Keogh

|Jan 21, 2022
Characterization of the Gut Microbiota in Individuals with Overweight or Obesity during a Real-World Weight Loss Dietary Program: A Focus on the Bacteroides 2 Enterotype.

Rohia Alili, Eugeni Belda, Odile Fabre

Pageof 2

Frequent Collaborators

3 joint publications

Judith Aron-Wisnewsky

3 joint publications

Christine Poitou

3 joint publications

Jean-Daniel Zucker

2 joint publications

Trine Nielsen